ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,829 | -24.6% | 15,550 | 0.0% | 0.04% | -20.4% |
| Q2 2023 | $554,513 | +40.4% | 15,550 | 0.0% | 0.05% | +32.4% |
| Q1 2023 | $394,970 | -37.4% | 15,550 | 0.0% | 0.04% | -41.3% |
| Q4 2022 | $630,708 | +22.7% | 15,550 | 0.0% | 0.06% | +12.5% |
| Q3 2022 | $514,000 | -6.2% | 15,550 | 0.0% | 0.06% | -1.8% |
| Q2 2022 | $548,000 | -23.4% | 15,550 | 0.0% | 0.06% | -6.6% |
| Q1 2022 | $715,000 | -30.6% | 15,550 | 0.0% | 0.06% | -29.1% |
| Q4 2021 | $1,031,000 | +6.2% | 15,550 | 0.0% | 0.09% | -6.5% |
| Q3 2021 | $971,000 | -24.6% | 15,550 | 0.0% | 0.09% | -8.0% |
| Q2 2021 | $1,288,000 | +24.9% | 15,550 | 0.0% | 0.10% | -4.8% |
| Q1 2021 | $1,031,000 | -13.6% | 15,550 | 0.0% | 0.10% | -23.9% |
| Q4 2020 | $1,193,000 | +307.2% | 15,550 | +128.7% | 0.14% | +220.9% |
| Q3 2020 | $293,000 | -67.1% | 6,800 | -67.0% | 0.04% | -71.1% |
| Q2 2020 | $890,000 | +50.1% | 20,600 | 0.0% | 0.15% | +26.3% |
| Q1 2020 | $593,000 | -53.5% | 20,600 | +2.5% | 0.12% | -41.9% |
| Q4 2019 | $1,275,000 | +125.3% | 20,100 | 0.0% | 0.20% | +109.3% |
| Q3 2019 | $566,000 | +6.2% | 20,100 | 0.0% | 0.10% | +4.3% |
| Q2 2019 | $533,000 | +44.4% | 20,100 | 0.0% | 0.09% | +43.1% |
| Q1 2019 | $369,000 | +47.6% | 20,100 | 0.0% | 0.06% | +27.5% |
| Q4 2018 | $250,000 | -35.1% | 20,100 | 0.0% | 0.05% | -30.1% |
| Q3 2018 | $385,000 | +41.0% | 20,100 | 0.0% | 0.07% | +32.7% |
| Q2 2018 | $273,000 | +83.2% | 20,100 | -2.4% | 0.06% | +83.3% |
| Q1 2018 | $149,000 | +96.1% | 20,600 | 0.0% | 0.03% | +100.0% |
| Q4 2017 | $76,000 | – | 20,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |